Cargando…

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy

This study was conducted to investigate whether polymorphisms of genes involved in immune checkpoints can predict the clinical outcomes of patients with advanced stage non-small cell lung cancer (NSCLC) after 1st line paclitaxel-cisplatin chemotherapy. A total of 379 NSCLC patients were enrolled. Tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Shin Yup, Jung, Deuk Kju, Choi, Jin Eun, Jin, Cheng Cheng, Hong, Mi Jeong, Do, Sook Kyung, Kang, Hyo-Gyoung, Lee, Won Kee, Seok, Yangki, Lee, Eung Bae, Jeong, Ji Yun, Shin, Kyung Min, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867646/ https://www.ncbi.nlm.nih.gov/pubmed/27181838 http://dx.doi.org/10.1038/srep25952

Ejemplares similares

Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgery
por: Lee, Shin Yup, et al.
Publicado: (2015)

Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer
por: Lee, Shin Yup, et al.
Publicado: (2016)

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2016)

Intronic variant of EGFR is associated with GBAS expression and survival outcome of early‐stage non‐small cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2018)

TSC2 genetic variant and prognosis in non‐small cell lung cancer after curative surgery
por: Lee, Yong Hoon, et al.
Publicado: (2018)

The effect of susceptibility variants, identified in never-smoking female lung cancer cases, on male smokers
por: Yoo, Seung Soo, et al.
Publicado: (2020)

Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early‐stage non‐small‐cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2018)

Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer
por: Kang, Hyo Gyoung, et al.
Publicado: (2017)

Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022)

The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology
por: Lee, Soyeon, et al.
Publicado: (2016)

Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer
por: Choi, Sun Ha, et al.
Publicado: (2022)

Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
por: Park, Ji Eun, et al.
Publicado: (2021)

TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2015)

Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma
por: Choi, Sun Ha, et al.
Publicado: (2020)

Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma
por: Kang, Hyo-Gyoung, et al.
Publicado: (2021)

Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma
por: Lee, Yong Hoon, et al.
Publicado: (2023)

Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population
por: Do, Sook Kyung, et al.
Publicado: (2015)

Association between polymorphisms in microRNA target sites and survival in early‐stage non‐small cell lung cancer
por: Yoo, Seung Soo, et al.
Publicado: (2017)

Genetic variants in key necroptosis regulators predict prognosis of non‐small cell lung cancer after surgical resection
por: Lee, Jang Hyuck, et al.
Publicado: (2023)

Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2023)

Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
por: Lee, Sunwoong, et al.
Publicado: (2023)

Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis
por: Yoo, Seung Soo, et al.
Publicado: (2020)

Detection of Deep Vein Thrombosis by Follow-up Indirect Computed Tomography Venography after Pulmonary Embolism
por: Lee, Hye Jin, et al.
Publicado: (2018)

A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection
por: Lee, Shin Yup, et al.
Publicado: (2015)

Telomerase Activity and the Risk of Lung Cancer
por: Jeon, Hyo-Sung, et al.
Publicado: (2012)

A Functional Polymorphism in the CHRNA3 Gene and Risk of Chronic Obstructive Pulmonary Disease in a Korean Population
por: Lee, Jae Yeon, et al.
Publicado: (2012)

Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

Relationship Between Clinical Features and Computed Tomographic Findings in Hospitalized Adult Patients With Community-Acquired Pneumonia()
por: Seo, Hyewon, et al.
Publicado: (2018)

Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin
por: Baek, Seung Woo, et al.
Publicado: (2012)

RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer
por: Choi, Yi-Young, et al.
Publicado: (2015)

EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
por: Jin, Guang, et al.
Publicado: (2012)

Predictors of Relapse in Patients with Organizing Pneumonia
por: Kim, Minjung, et al.
Publicado: (2015)

Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2016)

Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
por: Bae, Eun Young, et al.
Publicado: (2011)

Prognostic Value of Serum Growth Differentiation Factor-15 in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Miyoung, et al.
Publicado: (2014)

Can emphysema influence size discrepancy between radiologic and pathologic size measurement in subsolid lung adenocarcinomas?
por: Lim, Jae‐Kwang, et al.
Publicado: (2019)

Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
por: Park, Ji Eun, et al.
Publicado: (2020)

Comparison of Early and Late Tuberculosis Deaths in Korea
por: Lee, Jaehee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mvh5sogpsb77ch9evv8piogbah